Sponsors need to develop a strategy on how to evaluate the impact of the pandemic on the re-start of halted trials.
Agnieszka Pirinen
Advertisement
Articles by Agnieszka Pirinen
Advertisement
Latest Updated Articles
The Only Thing Certain is the Uncertainty: How to Re-Plan Future Clinical Trial Enrollment in Covid-19 TimesPublished: May 26th 2020 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
